Notably, the allele frequency associated with the KDR and KIT mutations was >40% in both tumor DNA and ccfDNA, which may have been an artifact of selective amplification or identification of single nucleotide polymorphisms because the allele frequency seems disproportionate to disease severity and changed minimally in ccfDNA samples acquired after metastatic disease developed. This evidence concerns the gene KIT and metastatic neoplasm.